Filing Details

Accession Number:
0001453687-22-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-13 21:07:18
Reporting Period:
2022-04-11
Accepted Time:
2022-04-13 21:07:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Selecta Biosciences Inc SELB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055624 A Timothy Springer 36 Woodman Road
Chestnut Hill MA 02467
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-11 6,681,600 $0.00 29,868,490 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2022-04-11 5,011,200 $0.00 5,011,200 $1.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,011,200 2022-04-11 2027-04-11 No 4 A Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,293,625 Direct
Common Stock 86,418 Indirect By wife
Footnotes
  1. Each share of common stock and accompanying warrant to purchase 0.75 shares of common stock was purchased at a combined ofering price of $1.41. The shares of common stock and accompanying warrants were acquired by the reporting person as units, but were issued separately and were immediately separable upon issuance.
  2. Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.